Home Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya)
Article
Licensed
Unlicensed Requires Authentication

Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya)

  • Ira Purbosari , Bambang Zubakti Zulkarnain , Muh Aminuddin and Umi Fatmawati
Published/Copyright: June 25, 2021

Abstract

Objectives

Heart disease is a clinical condition characterized by specific signs such as joint inflammation, weakness, and shortness of breath. Left ventricular remodeling can be experienced by patients with heart failure wherein a change in myocyte and nonmyocyte components occurs. One of the biomarkers in heart disease with myocardial fibrosis is matrix metalloproteinase-9 (MMP-9). Common therapy that is often given to patients with heart failure is ACE inhibitors. This main objective of this research is to investigate the effect of ACE inhibitor therapy on the degrees of MMP-9 as a biomarker among patients with heart disease.

Methods

This research applied one group pretest–posttest design to analyze the variation in the levels of MMP-9 as a biomarker for heart function. Twenty-three subjects with acute heart disease met that inclusion also exclusion criteria, who were selected using nonrandom sampling. Statistical analysis was conducted to specify the levels of MMP-9 before, after the administration of therapy.

Results

The most widely used ACE inhibitor drug was ramipril for 15 patients (65%), and the least used ACE Inhibitor drug was captopril for two patients (9%). Meanwhile, the mean MMP-9 levels before therapy was (1,915.26 pg/mL ± 260.84), and the mean MMP-9 levels after therapy was (1,916.93 pg/mL ± 383.12). The statistical analysis result revealed no significant difference in the degrees of Matrix Metalloproteinase-9 accumulation (p=0.378).

Conclusions

There was no significant reduction in the levels of Matrix Metalloproteinase-9 after pretest and posttest.


Corresponding author: Bambang Zubakti Zulkarnain, Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia, Phone: +62 8113419355, E-mail:

Acknowledgments

Gratitude is due to the Director of Dr. Soetomo General Hospital, the Head of the Cardiology and Vascular Outpatient Clinic at Dr. Soetomo Hospital Surabaya and Tahir Professorship.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: This study was designed to comply the criteria for ethical conduct and was approved by the Health Research Ethics Committee of Dr. Soetomo General Hospital, with reference number No.1227/KEPK/V/2019.

References

1. Yancy, CW, Jessup, M, Bozkurt, B, Butler, J, Casey, DE, Colvin, MM, et al.. 2017 ACC/AHA/HFSA focused update of the 2013 ACC/AHA guideline for the management of heart failure a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and Heart Failure Society America. Circulation 2017;80:777–803. https://doi.org/10.1016/j.cardfail.2017.04.014.Search in Google Scholar

2. Ponikoswskip, P, Voors, AA, Anker, SD, Bueno, H, Cleland, JGF, Coats, AJ, et al.. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;372:2129–200. https://doi.org/10.1093/eurheartj/ehw128.Search in Google Scholar

3. Kementrian Kesehatan, RI. Laporan nasional Riskesdas 2018. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2018:146–53 pp.Search in Google Scholar

4. Mann, DL, Chakinala, M. Heart failure: pathophysiology and diagnosis. In: Kasper, D, Fauci, A, Hauser, S, Longo, D, Jameson, JL, Loscalzo, J, editors. Harrison’s principles of internal medicine, 19th ed. New York, NY: McGraw-Hill Education; 2014.Search in Google Scholar

5. Liu, P, Sun, M, Sader, S. Matrix metalloproteinases in cardiovascular disease. Can J Cardiol 2006;22(B Suppl):25B–30. https://doi.org/10.1016/s0828-282x(06)70983-7.Search in Google Scholar

6. Anand, I, Florea, V Alteration in ventricular structure. Role of left ventricular remodelling. In Heart failure. Elsevier Inc; 2011:232–53. https://doi.org/10.1016/b978-1-4160-5895-3.10015-4.Search in Google Scholar

7. Braunwald, E Heart failure. J Am Coll Cardiol 2013;1:1–20. https://doi.org/10.1016/j/jchf.2012.10.002.Search in Google Scholar

8. Karayannis, G, Triposkiadis, F, Skoularigis, J, Georgoulias, P, Butler, J, Giamouzis, G. The emerging role of galectin-3 and SST2 in heart failure: practical considerations and pitfalls using novel biomarkers. Curr Heart Fail Rep 2013;10:44–9. https://doi.org/10.1007/s11897-103-0169-1.Search in Google Scholar

9. Morishita, T, Uzui, H, Mitsuke, Y, Amaya, N, Kaseno, K, Ishida, K, et al.. Association between matrix metalloproteinase-9 and worsening heart failure events in patients with chronic heart failure. ESC Heart Fail 2017;4:321–30. https://doi.org/10.1002/ehf2.12137.Search in Google Scholar

10. Baggen, VJM, Eindhoven, JA, van den Bosch, AE, Witsenburg, M, Cuypers, JAAE, Langstraat, JS, et al.. Matrix metalloproteinases as candidate biomarkers in adults with congenital heart disease. Biomarkers 2016;21:466–73. 869247. https://doi.org/10.3109/1354750x.2016.1153722.Search in Google Scholar

11. Milfred-LaForest, SK, Chow, SL, DiDomenico, RJ, Dracup, K, Ensor, CR, Gattis-Stough, W, et al.. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacother J Hum Pharmacol Drug Ther 2013;33:529–48. https://doi.org/10.1016/j.cardfail.2013.02.002.Search in Google Scholar

12. Zhao, Z, Wang, H, Jessup, J. Role of estrogen in diastolic dysfunction. Am J Physiol Heart Circ Physiol 2014;306:628–40. https://doi.org/10.1152/ajpheart.00859.2013.Search in Google Scholar

13. Reddy, KS. Global perspective in cardiovascular disease. In: yusuf, S, Chairm, JA. Evidance-based cardiology, 3rd ed. British Medical Journal Wiley Publishing Group; 2010:596–601 pp.10.1002/9780470986882.ch9Search in Google Scholar

14. Pitt, B, zannad, F, Remme, WJ, Cody, R, Castaigne, A, Perez, A. The effect of spironolakton on morbidity and mortality in patient with severe heart failure. Randomized aldacton evaluation study investigator. N Engl J Med 1999;341:709–17. https://doi.org/10.1056/NEJM199909023411001.Search in Google Scholar

15. Savarese, G, Lund, LH. Global public health burden of heart failure. Card Fail Rev 2017;3:7–11. https://doi.org/10.15420/cfr.2016:25:2.10.15420/cfr.2016:25:2Search in Google Scholar

16. Libby, P. 2016 coronary and peripheral vascular disease, 19th ed. New York, NY: McGraw-Hill Education; 2016:1578–99 pp.Search in Google Scholar

17. Rosano, GM, Vitale, C, Seferovic, P. Heart failure in patients with diabetes mellitus. Card Fail Rev 2017;3:52–5. https://doi.org/10.15420/cfr.2016:20:2.10.15420/cfr.2016:20:2Search in Google Scholar

18. Bonow, RO, Mann, DL, Zipers, DP, Libby, P. Braunwald’s heart disease: a textbook of cardiovascular medicine. Single Volume – 9th ed. 2011 [Internet]. Available from: https://www.elsevier.com/books/braunwalds-heart-disease-a-textbook-of-cardiovascular-medicine-single-volume/bonow/978-1-4377-0398-6 [Cited 25 Nov 2020].Search in Google Scholar

19. Opie, LH, Gersh, BJ. Drugs for the heart. Philadelphia, PA: Elsevier Saunders; 2013.Search in Google Scholar

20. Singh, H, Marrs, J. Applied therapeutics: the clinical use of drug. Philadelphia: Wolters Kluwer; 2018:261–305 pp.Search in Google Scholar

21. Sun, W, Zhang, H, Guo, J, Zhang, X, Zhang, L, Li, C, et al.. Comparison of the efficacy and safety of different ACE inhibitors in patients with chronic heart failure. Medicine (Baltim) 2016;95 [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753869/, https://doi.org/10.1097/MD.0000000000002554 [Cited 25 Nov 2020].Search in Google Scholar

22. Hunt, SA, Abraham, WT, Chin, MH, Feldman, AM, Francis, GS, Ganiats, TG, et al.. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. Circulation 2009;119:e391–479. https://doi.org/10.1161/CIRCULATIONAHA.109.192065.Search in Google Scholar

23. Van Kimmenade, RR, Januzzi, JL. Emerging biomarkers in heart failure. Clin Chem 2012;58:1–29. DOI: 10.1161/CIRCRESAHA.118.312706.10.1373/clinchem.2011.165720Search in Google Scholar

Received: 2021-01-06
Accepted: 2021-04-08
Published Online: 2021-06-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Cost of illness of diabetes mellitus in Indonesia: a systematic review
  4. Social media health interventions to improve diabetes mellitus patient outcome: a systematic review
  5. Developing pharmacokinetics–pharmacodynamics model of valproic acid syrup based on prediction of population pharmacokinetics parameter and seizure frequency in Indonesian pediatric epilepsy outpatients
  6. Acetylcholinesterase inhibitory activity of extract and fractions from the root of Rauvolfia serpentina(L.) Bth.ex Kurz
  7. Green tea and its active compound epigallocathechin-3-gallate (EGCG) inhibit neuronal apoptosis in a middle cerebral artery occlusion (MCAO) model
  8. The effects of quercetin on nicotine-induced reward effects in mice
  9. Resveratrol ameliorates physical and psychological stress-induced depressive-like behavior
  10. Translation and cross-cultural adaption of an instrument measuring patient’s well-being under treatment for schizophrenia
  11. Quercetin promotes behavioral recovery and biomolecular changes of melanocortin-4 receptor in mice with ischemic stroke
  12. Knowledge and attitudes of healthcare professionals on prescribing errors
  13. Inhibition of Ras and STAT3 activity of 4-(tert-butyl)-N-carbamoylbenzamide as antiproliferative agent in HER2-expressing breast cancer cells
  14. Predicting the molecular mechanism of glucosamine in accelerating bone defect repair by stimulating osteogenic proteins
  15. Larvicidal toxicity and parasporal inclusion of native Bacillus thuringiensis BK5.2 against Aedes aegypti
  16. Synthesis, ADMET predictions, molecular docking studies, and in-vitro anticancer activity of some benzoxazines against A549 human lung cancer cells
  17. Thymoquinone and its derivatives against breast cancer with HER2 positive: in silico studies of ADMET, docking and QSPR
  18. Assessment of patient understanding of their conventional cardiac medicines and herbal prepared/derived products: preliminary survey and interviews with selected community-dwelling elderly patients in the Philippines
  19. The development and validation of the health belief model questionnaire for measuring factors affecting adherence in the elderly with hypertension
  20. Analysis of the side effect of QTc interval prolongation in the bedaquiline regimen in drug resistant tuberculosis patients
  21. Shallot skin profilling, computational evaluation of physicochemical properties, ADMET, and molecular docking of its components against P2Y12 receptor
  22. Analysis of HMGB-1 level before and after providing atorvastatin standard therapy in coronary artery disease patients with type-2 diabetes mellitus compared to without type-2 diabetes mellitus
  23. Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya)
  24. The correlation between self-related adherence, asthma-related quality of life and control of asthma in adult patients
  25. Providing counseling through home pharmacy care (HPC) for hemodialysis patients with hypertension in lowering blood pressure
  26. Community knowledge and attitude in recognizing asthma symptoms and using medication for asthma attacks: a cross-sectional study
  27. A study of anticoagulant therapy in patients with coronary artery disease
  28. The association of FKBP5 polymorphism with asthma susceptibility in asthmatic patients
  29. Gastroprotective effect of fluvoxamine and ondansetron on stress-induced gastric ulcers in mice
  30. Osteoblast iron genes: real time PCR and microarray hybridization approach under hyperoxia
  31. Attenuation of hyperplasia in lung parenchymal and colonic epithelial cells in DMBA-induced cancer by administering Andrographis paniculata Nees extract using animal model
  32. N-nitrosodiethylamine induces inflammation of liver in mice
  33. AST/ALT levels, MDA, and liver histopathology of Echinometra mathaei ethanol extract on paracetamol-induced hepatotoxicity in rats
  34. Development, characterization, molecular docking, and in vivo skin penetration of coenzyme Q10 nanostructured lipid carriers using tristearin and stearyl alcohol for dermal delivery
  35. The effect of Camellia sinensis (green tea) with its active compound EGCG on neuronal cell necroptosis in Rattus norvegicus middle cerebral artery occlusion (MCAO) model
  36. Hepatoprotective effect of ethanolic extract of sugarcane (Saccharum officinarum Linn.) leaves
  37. Correlation between the exposure time to mobile devices and the prevalence of evaporative dry eyes as one of the symptoms of computer vision syndrome among Senior High School students in East Java, Indonesia
  38. The effect of various high-fat diet on liver histology in the development of NAFLD models in mice
  39. Fabrication and characterization of bovine hydroxyapatite-gelatin-alendronate scaffold cross-linked by glutaraldehyde for bone regeneration
  40. Health related quality of life among postmenopausal woman with hormone responsive HER2− breast cancer in Indonesia
  41. Gender differences in the blood glucose type 2 diabetes patients with combination rapid and long acting insulin therapy
  42. Correlation of dietary iron intake and serum iron with thyroid stimulating hormone (TSH) and free thyroxine (FT4) levels in adult hyperthyroid patients
  43. The effect of pillbox use and education by pharmacist toward medication adherence in diabetes mellitus patients in a Primary Health Care Center in Mataram
  44. Variation concentration effect of propyleneglycol, glycerin, and polyethyleneglycol 400 to physical properties and dissolution rate of loratadine liquisolid tablet
  45. Role of Centella asiatica and ceramide in skin barrier improvement: a double blind clinical trial of Indonesian batik workers
  46. Secondary metabolite and antipyretic effects of Maja (Crescentia cujete L.) in fever-induced mice
  47. Hydration effect on kidney function and serum electrolyte in children with tumor lysis syndrome (TLS) and risk of TLS
  48. Drug utilization study and cost analysis of adult β-thalassemia major patient therapy at Dr. Soetomo General Hospital Surabaya
  49. The role of hyperbaric oxygen to platelet aggregation in noninsulin-dependent diabetes mellitus (NIDDM)
  50. Cocrystal formation of loratadine-succinic acid and its improved solubility
  51. The role of chondroitin sulfate to bone healing indicators and compressive strength
  52. The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice
  53. Analysis of stress ulcer prophylaxis drug regimentation in surgical patients
  54. The stability and irritability study of the chitosan–Aloe vera spray gel as wound healing
  55. Effectiveness of citicoline in pediatric patients with refractive amblyopia in Surabaya, East Java, Indonesia
  56. The thermodynamic study of p-methoxycinnamic acid inclusion complex formation, using β-cyclodextrin and hydroxypropyl-β-cyclodextrin
  57. The effect of chitosan type and drug-chitosan ratio on physical characteristics and release profile of ketoprofen microparticles prepared by spray drying
  58. The maximum dose and duration in the therapy single use methotrexate to achieve remission by rheumatoid arthritis patients through disease activity score 28 (DAS28)
  59. Knowledge, attitudes, and practices (KAP) towards COVID-19 among university students in Pakistan: a cross-sectional study
  60. The impact of glutaraldehyde on the characteristics of bovine hydroxyapatite-gelatin based bone scaffold as gentamicin delivery system
  61. Analysis of the use of antibiotics profile and factors of surgical site infections study on digestive and oncology surgeries
  62. Second internal transcribed spacer (ITS-2) as genetic marker for molecular characterization of Sarcoptes scabiei in rabbits from several areas of East Java, Indonesia
  63. Design of gossypetin derivatives based on naturally occurring flavonoid in Hibiscus sabdariffa and the molecular docking as antibacterial agents
  64. Discovery of new targeting agents against GAPDH receptor for antituberculosis drug delivery
  65. The effect of red passion fruit (Passiflora edulis Sims.) fermentation time on its activity against Extended Strain Methicillin-Resistant (ESBL) Escherichia coli and Methicillin-Resistant Staphylococcus aureus (MRSA)
  66. Antibiotic use on acute respiratory tract infection nonpneumonia and nonspecific diarrhea in Primary Health Care Centre in Banjarbaru City, South Kalimantan, Indonesia
  67. Screening of anti-HIV activities in ethanol extract and fractions from Ficus fistulosa leaves
  68. The characteristics of lactic acid bacteria isolated from fermented food as potential probiotics
  69. Profile of gyrA gene mutation in clinical isolate of levofloxacin resistant Escherichia coli
  70. Antimicrobial activity of Centella asiatica and Gigantochloa apus
  71. Drug-related problems of antibiotic use in gastroenteritis related to patient therapy outcomes at Universitas Gadjah Mada Hospital
  72. The impact of suitability of empirical antibiotics use on therapeutic outcome of respiratory tract infection patients at inpatient wards of Universitas Gadjah Mada Academic Hospital
  73. Genetic profile mutation rpoB in clinical isolate of rifampicin-resistant Staphylococcus aureus
  74. Hematological side effect analysis of linezolid in MDR-TB patients with individual therapy
  75. Adverse drug reaction and its management in tuberculosis patients with multidrug resistance: a retrospective study
  76. Analysis of prophylactic antibiotic use and risk factor of postoperative infection in urological surgery patients
  77. Molecular docking studies of Nigella sativa L and Curcuma xanthorrhiza Roxb secondary metabolites against histamine N-methyltransferase with their ADMET prediction
  78. Prediction of compounds with antiosteoporosis activity in Chrysophyllum cainito L. leaves through in silico approach
  79. Phyllanthin and hypophyllanthin, the isolated compounds of Phyllanthus niruri inhibit protein receptor of corona virus (COVID-19) through in silico approach
  80. Cratoxylum sumatranum stem bark exhibited antimalarial activity by Lactate Dehydrogenase (LDH) assay
  81. Endophytic fungi inhabiting Physalis angulata L. plant: diversity, antioxidant, and antibacterial activities of their ethyl acetate extracts
  82. Exploration of several plants from Baung Forest on bone formation cell models
  83. In vitro antimalarial activity of Garcinia parvifolia Miq. Stem extracts and fractions on Plasmodium falciparum lactate dehydrogenase (LDH) assay
  84. Antioxidant and antiviral potency of Begonia medicinalis fractions
  85. Artocarpus sericicarpus stem bark contains antimalarial substances against Plasmodium falciparum
  86. Formulation and characterization of Eleutherine palmifolia extract-loaded self-nanoemulsifying drug delivery system (SNEDDS)
  87. Analytical method for the determination of curcumin entrapped in polymeric micellar powder using HPLC
  88. Challenges in the provision of natural medicines by community pharmacists in East Java Province, Indonesia
  89. In vitro and in silico analysis of phytochemical compounds of 96% ethanol extract of semanggi (Marsilea crenata Presl.) leaves as a bone formation agent
  90. Inhibitory activity of Urena lobata leaf extract on alpha-amylase and alpha-glucosidase: in vitro and in silico approach
  91. Case Report
  92. Effect of hydrocortisone on hypocorticolism caused by pituitary adenoma
Downloaded on 26.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2020-0465/html?lang=en
Scroll to top button